Back to RARE
STATE STREET CORP RARE Position History
Ultragenyx Pharmaceutical Inc. • Healthcare
Quarters held
12
Latest value
$205.6M
Q2 2026
Peak value
$205.6M
First seen
Q4 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2023 | $155.5M |
| Q1 2024 | $133.1M |
| Q2 2024 | $110.9M |
| Q3 2024 | $148M |
| Q4 2024 | $114.5M |
| Q1 2025 | $94.8M |
| Q2 2025 | $93.5M |
| Q3 2025 | $111.1M |
| Q4 2025 | $99M |
| Q1 2026 | $105.2M |
| Q2 2026 | $205.6M |
| Q2 2026 | $205.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $205.6M | 6.16M | — | — |
| Q2 2026 | $205.6M | 6.16M | — | — |
| Q1 2026 | $105.2M | 5.02M | — | — |
| Q4 2025 | $99M | 4.30M | — | — |
| Q3 2025 | $111.1M | 3.69M | — | — |
| Q2 2025 | $93.5M | 2.57M | — | — |
| Q1 2025 | $94.8M | 2.62M | — | — |
| Q4 2024 | $114.5M | 2.72M | — | — |
| Q3 2024 | $148M | 2.66M | — | — |
| Q2 2024 | $110.9M | 2.70M | — | — |
| Q1 2024 | $133.1M | 2.85M | — | — |
| Q4 2023 | $155.5M | 3.25M | — | — |
Other funds holding RARE
$365.5M
$356.7M
$283.9M
$219.1M
$213.3M
$120.9M
$107.7M